Related Experiment Video

Updated: Jul 16, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H)

L K Csatary1, R W Moss, J Beuth

  • 1United Cancer Research Institute, Alexandria, VA, USA.

Anticancer Research
|April 27, 1999
PubMed

Insights

Newcastle Disease Virus Vaccine (MTH-68/H) shows promise for advanced cancers. Further clinical trials are proposed to confirm these promising effects in cancer patients.

Area of Science:

  • Oncology
  • Virology
  • Immunotherapy

Background:

  • Advanced neoplastic diseases often have limited treatment options.
  • Newcastle Disease Virus (NDV) has been explored as an oncolytic agent.
  • MTH-68/H is a specific strain of NDV vaccine.

Observation:

  • Case reports indicate potential efficacy of NDV vaccine (MTH-68/H) in patients with advanced cancers.
  • Patients received the vaccine after non-efficient tumor-destructive treatments.
  • The observed effects suggest a possible therapeutic benefit.

Findings:

  • Preliminary data from case reports suggest promising anti-cancer effects.
  • The MTH-68/H strain of NDV may possess oncolytic properties.
  • Further investigation is warranted to validate these initial observations.

Implications:

  • This research could lead to novel therapeutic strategies for advanced cancers.
  • Confirmation of these findings may support the development of NDV-based cancer vaccines.
  • A prospectively-randomized clinical study is under consideration to validate these results.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid07:24

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid

Published on: May 25, 2022

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...